10 MG · Research Grade
Retatrutide
Next-Generation Metabolic Peptide
A triple-agonist investigational peptide that simultaneously activates GIP, GLP-1 and Glucagon receptors — three critical pathways involved in metabolic regulation and energy balance.
Potential Research Benefits
- Supports metabolic regulation
- Promotes weight-management pathways
- Enhances insulin sensitivity
- Supports energy expenditure
- May improve glucose homeostasis
How It Works
By targeting GIP, GLP-1 and Glucagon receptors, Retatrutide works synergistically to reduce appetite, improve lipolysis and increase energy expenditure. In research it has shown up to 24% mean body-weight reduction (Phase 2, investigational).
Specifications
CAS Number
2381089-83-2
Form
Lyophilized Peptide
Purity
≥ 99% (HPLC)
Storage
Store cold 2–8°C
⚠ Research Use Only — Not for Human Consumption. For laboratory research purposes only.